Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin-A in Men With Androgenetic Alopecia
NCT00965640Phase 2Completed
- Sponsor
- Renée Crown Wellness Institute
- Start
- Dec 2002
- Primary completion
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in androgenetic alopecia (AGA), sponsored by Renée Crown Wellness Institute. Started Dec 2002; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT00965640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965640.